Where to Next for Theranostics in Prostate Cancer?

Affiliations

¹ Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. Electronic address: declan.murphy@petermac.org.
² Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.
³ The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Molecular Imaging and Nuclear Medicine Therapeutics, Peter MacCallum Cancer Centre, Melbourne, Australia.
⁴ The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Division of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
⁵ Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Surgery, University of Melbourne, Austin Hospital, Heidelberg, Australia.

Editorial

Declan G Murphy et al. Eur Urol Oncol. 2019 Mar.

. 2019 Mar;2(2):163-165.

doi: 10.1016/j.euo.2019.03.004. Epub 2019 Mar 29.

¹ Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia. Electronic address: declan.murphy@petermac.org.
² Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia.
³ The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Molecular Imaging and Nuclear Medicine Therapeutics, Peter MacCallum Cancer Centre, Melbourne, Australia.
⁴ The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia; Division of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
⁵ Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Surgery, University of Melbourne, Austin Hospital, Heidelberg, Australia.

No abstract available

Comment on

Theranostics for Advanced Prostate Cancer: Current Indications and Future Developments.
Farolfi A, Fendler W, Iravani A, Haberkorn U, Hicks R, Herrmann K, Walz J, Fanti S. Farolfi A, et al. Eur Urol Oncol. 2019 Mar;2(2):152-162. doi: 10.1016/j.euo.2019.01.001. Epub 2019 Jan 31. Eur Urol Oncol. 2019. PMID: 31017091 Review.